Home Health News Trump Finishes Controversial Malaria Drug Course to Combat Virus – MSN Money

Trump Finishes Controversial Malaria Drug Course to Combat Virus – MSN Money

3 min read

(Bloomberg) —  President Donald Trump said he completed his course of treatment with hydroxychloroquine, the anti-malaria drug he’s promoted as a therapy for coronavirus despite an outcry from medical professionals about its unproven efficacy and potential side effects.

A pharmacy tech holds a bottle of Hydroxychloroquine at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. – US President Donald Trump announced May 18 he has been taking hydroxychloroquine for almost two weeks as a preventative measure against COVID-19. (Photo by GEORGE FREY / AFP) (Photo by GEORGE FREY/AFP via Getty Images)

“Finished, just finished,” Trump said in an interview on Sinclair Broadcast Group program “Full Measure with Sharyl Attkisson” that was taped Friday and aired Sunday. “By the way, I’m still here to the best of my knowledge. Here I am.”

There’s scant evidence that hydroxychloroquine is effective against the coronavirus. The Food and Drug Administration on April 24 cautioned against its use for Covid-19, the illness caused by the coronavirus, outside of a hospital setting or clinical trial, citing a risk of heart rhythm problems.

Hydroxychloroquine Tied to Deaths, Heart Risk in Covid Study

Trump, who at 73 is in an age group at which contracting Covid-19 can be especially dangerous, began the treatments in consultation with White House physicians after Vice President Mike Pence’s press secretary, Katie Miller, tested positive for coronavirus on May 8. A White House valet also contracted the virus around the same time.

“I believe in it enough that I took a program, because I had two people in the White House that tested positive, I figured maybe it’s a good thing to take a program,” Trump said.

“You know we take a little bit of a period of time, I think it was two weeks, but hydroxy has had tremendous, if you look at it, tremendous, rave reviews.”

For more articles like this, please visit us at bloomberg.com

©2020 Bloomberg L.P.

Let’s block ads! (Why?)

Source link

Load More Related Articles
Load More By admin
Load More In Health News

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

China’s Covid-19 vaccine diplomacy steals a march on US – Financial Times

China is promising preferential access to its Covid-19 vaccines to countries across Asia, …